ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2832

Novel Gene Variants Associated with Cardiovascular Disease in Systemic Lupus Erythematosus

Dag Leonard1, Andrei Alexsson1, Johanna Dahlqvist2, Kimberly Taylor3, Johanna K Sandling4, Christine Bengtsson5, Elisabet Svenungsson6, Christopher Sjöwall7, Andreas Jönsen8, Iva Gunnarsson6, Anders A. Bengtsson8, Solbritt Rantapaa-Dahlqvist5, Maija-Leena Eloranta1, Ann-Christine Syvänen4, Lindsey A. Criswell9 and Lars Rönnblom1, 1Uppsala University, Department of Medical Sciences, Rheumatology and Science for Life Laboratory, Uppsala, Sweden, 2Uppsala University, Department of Medical Biochemistry and Microbiology Science for Life Laboratory, Uppsala, Sweden, 3University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA, 4Uppsala University, Department of Medical Sciences, Molecular Medicine and Science for Life Laboratory, Uppsala, Sweden, 5Umeå University, Department of Public Health and Clinical Medicine/ Rheumatology, Umeå, Sweden, 6Karolinska Institutet, Department of Medicine, Unit of Rheumatology, Stockholm, Sweden, 7Linköping University, Department of Clinical and Experimental Medicine Rheumatology/AIR, Linköping, Sweden, 8Lund University, Department of Clinical Sciences, Rheumatology, Lund, Sweden, 9Medicine, University of California, San Francisco, Rosalind Russell / Ephraim P. Engleman Rheumatology Research Center, San Francisco, CA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Bioinformatics, cardiovascular disease and genetics, Lupus, SLE

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Systemic Lupus Erythematosus – Clinical Aspects and Treatment - Poster III: Biomarkers and Nephritis

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Patients with Systemic Lupus Erythematosus (SLE) have increased risk of cardiovascular disease (CVD). We asked if single nucleotide polymorphisms (SNPs) analyzed by the Immunochip were associated to CVD in SLE, and followed up with bioinformatics and functional analyses.  

Methods: SLE patients (Sweden, n=1055) were genotyped using the 200K Immunochip SNP array (Illumina). The allele frequency was compared between patients with and without myocardial infarction (MI)/angina pectoris (AP), ischemic stroke (stroke)/transitory ischemic attack (TIA), pulmonary embolism/deep vein thrombosis and MI/stroke. Data was analyzed using a logistic regression model with sex and disease duration included as covariates. The SNPs showing the strongest association were re-analyzed in a second group of patients of European descent (United States, n=1043). Information regarding TIA and AP was not available for the US patients. Sex, disease duration and two principal components for population stratification were included as covariates. All patients fulfilled the 1982 ACR-criteria for SLE. Bioinformatic analysis was performed using several databases including RegulomeDB, GTEx and UCSC GB.

Results: An association between a locus located on chromosome 14 and stroke/TIA was shown in both the Swedish (OR 1.8, p=0.0002) and the US (OR 1.6, p=0.03) cohort. The SNP is located in an intron and is conserved in animals but not in humans. The gene variant is located in the middle of a Chip-seq peak for STAT1 and a few bases 3´of a USF2-peak. It is a predicted enhancer in B-cells and also an eQTL. By electrophoretic mobility shift assay (EMSA) we have demonstrated that STAT1 is one of the transcription factors binding at the risk loci. In both the Swedish (OR 2.6, p=0.0006) and US (OR 1.9, p=0.04) cohorts an association was demonstrated between a locus located on chromosome 1 and stroke/MI. The locus is a predicted enhancer in B-cells and is located in an intron 3´of a binding site for a cluster of transcription factors and at a Chip-Seq-peak for CTCF. By EMSA, differential protein binding between the alternative and reference allele was demonstrated using nuclear extract from T-cells activated by PMA/ionomycin. When comparing the level of IL10 in SLE patients with and without the risk gene variant the alternative allele was associated with higher serum levels of IL10 (n=255, p=0.001).

Conclusion: The results indicate that multiple genes in different pathways, including B cell function and cytokine signaling, are involved in the development of CVD in SLE. Thus, CVD in SLE is clearly dependent on the autoimmune and inflammatory disease process, which needs to be considered when therapeutic strategies are developed for the premature CVD observed in SLE patients.


Disclosure: D. Leonard, None; A. Alexsson, None; J. Dahlqvist, None; K. Taylor, None; J. K. Sandling, None; C. Bengtsson, None; E. Svenungsson, None; C. Sjöwall, None; A. Jönsen, None; I. Gunnarsson, None; A. A. Bengtsson, None; S. Rantapaa-Dahlqvist, None; M. L. Eloranta, None; A. C. Syvänen, None; L. A. Criswell, None; L. Rönnblom, None.

To cite this abstract in AMA style:

Leonard D, Alexsson A, Dahlqvist J, Taylor K, Sandling JK, Bengtsson C, Svenungsson E, Sjöwall C, Jönsen A, Gunnarsson I, Bengtsson AA, Rantapaa-Dahlqvist S, Eloranta ML, Syvänen AC, Criswell LA, Rönnblom L. Novel Gene Variants Associated with Cardiovascular Disease in Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/novel-gene-variants-associated-with-cardiovascular-disease-in-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/novel-gene-variants-associated-with-cardiovascular-disease-in-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology